These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3467134)

  • 21. Bactericidal activity of ciprofloxacin, norfloxacin and ofloxacin in serum and urine after oral administration to healthy volunteers.
    Zeiler HJ; Beermann D; Wingender W; Förster D; Schacht P
    Infection; 1988; 16 Suppl 1():S19-23. PubMed ID: 3286510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
    Guenounou M; Ronco E; Kodari E; Vacheron F; Momrikof V
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):785-9. PubMed ID: 3309816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
    Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
    Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of DNA gyrase by optically active ofloxacin.
    Imamura M; Shibamura S; Hayakawa I; Osada Y
    Antimicrob Agents Chemother; 1987 Feb; 31(2):325-7. PubMed ID: 3032098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antimycobacterial activities of minocycline and ciprofloxacin].
    Arai T; Komatsu S; Aoyagi T
    Kekkaku; 1985 May; 60(5):293-7. PubMed ID: 3162057
    [No Abstract]   [Full Text] [Related]  

  • 29. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of three fluoroquinolones against enterococci and Pseudomonas aeruginosa: modified categorization system for discrepant broth dilution and agar disk diffusion test results.
    Traub WH; Kohl KH; Spohr M
    Chemotherapy; 1988; 34(2):101-6. PubMed ID: 3134171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.
    Guelpa-Lauras CC; Perani EG; Giroir AM; Grosset JH
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):70-7. PubMed ID: 3549940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gyrase inhibitors modify metabolising processes in the liver].
    Staib AH; Harder S; Papenburg A; Stille W
    Dtsch Med Wochenschr; 1987 Oct; 112(44):1720-1. PubMed ID: 2822371
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
    Akkan AG; Mutlu I; Ozyazgan S; Gök A; Yigit U; Ozüner Z; Senses V; Pekel H
    Int J Clin Pharmacol Ther; 1997 May; 35(5):214-7. PubMed ID: 9174877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ciprofloxacin, clarithromycin, rifampin: in vitro bactericidal activity of double and triple drug combinations against strains of atypical mycobacteria].
    Ximenes E; Zuccarelli M; Dusart G; Simeon De Buochberg M
    Pathol Biol (Paris); 1993 Apr; 41(4):317-22. PubMed ID: 8233629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fluoroquinolones].
    Baykal M; Akalin E
    Mikrobiyol Bul; 1987 Apr; 21(2):151-7. PubMed ID: 3482120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dependence of the bactericidal activity and mutant selection of 4-quinolones on their serum concentration levels].
    Bauernfeind A; Petermüller C; Heinrich B; Gablac R
    Infection; 1986; 14 Suppl 1():S26-30. PubMed ID: 3082765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norfloxacin, ciprofloxacin, and ofloxacin: current clinical roles.
    Hooper DC; Wolfson JS
    Curr Clin Top Infect Dis; 1989; 10():194-240. PubMed ID: 2679694
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative effects of quinolones on human mononuclear leucocyte functions.
    Roche Y; Gougerot-Pocidalo MA; Fay M; Etienne D; Forest N; Pocidalo JJ
    J Antimicrob Chemother; 1987 Jun; 19(6):781-90. PubMed ID: 3497150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro and in vivo activities of cefoxitin alone or in combination with antituberculosis drugs against the Mycobacterium fortuitum complex].
    Sato K; Saito H; Tomioka H
    Kekkaku; 1987 Jul; 62(7):383-8. PubMed ID: 3682558
    [No Abstract]   [Full Text] [Related]  

  • 40. [In vitro activity of ofloxacin and ciprofloxacin against Mycobacterium tuberculosis strains].
    Aysev AD
    Mikrobiyol Bul; 1993 Jan; 27(1):31-5. PubMed ID: 8421440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.